1. Home
  2. OSUR vs STRO Comparison

OSUR vs STRO Comparison

Compare OSUR & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.43

Market Cap

177.2M

Sector

Health Care

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$10.46

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSUR
STRO
Founded
2000
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.2M
85.0M
IPO Year
1986
2018

Fundamental Metrics

Financial Performance
Metric
OSUR
STRO
Price
$2.43
$10.46
Analyst Decision
Hold
Hold
Analyst Count
2
8
Target Price
$3.00
$18.29
AVG Volume (30 Days)
659.3K
122.9K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$125,703,000.00
$105,646,000.00
Revenue This Year
N/A
$63.08
Revenue Next Year
$3.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.08
$5.23
52 Week High
$4.22
$21.50

Technical Indicators

Market Signals
Indicator
OSUR
STRO
Relative Strength Index (RSI) 46.98 81.15
Support Level $2.41 $8.49
Resistance Level $2.49 $11.09
Average True Range (ATR) 0.10 0.83
MACD 0.00 0.03
Stochastic Oscillator 27.12 89.41

Price Performance

Historical Comparison
OSUR
STRO

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: